The Color of Money on the Cote d Azur: At Industry Conference, Players Search for the Right Deals | GenomeWeb

CANNES, France, Sept. 10 – Some two-dozen genomic and pharmaceutical companies, 20 private start-up life sciences firms, one bioethicist, and a gaggle of venture capitalists, financiers, institutional funds, and banks descended on this Mediterranean city on Sunday to learn what the future of life sciences may look like and, hopefully, to do deals.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.